<VariationArchive RecordType="classified" VariationID="374841" VariationName="NC_000012.11:g.114795705_114844082dup" VariationType="Duplication" Accession="VCV000374841" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-01-23" MostRecentSubmission="2017-01-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="361746" VariationID="374841">
      <GeneList>
        <Gene Symbol="TBX5" FullName="T-box transcription factor 5" GeneID="6910" HGNC_ID="HGNC:11604" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="114353911" stop="114408442" display_start="114353911" display_stop="114408442" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114791734" stop="114846246" display_start="114791734" display_stop="114846246" Strand="-" />
          </Location>
          <OMIM>601620</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000012.11:g.114795705_114844082dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q24.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114795705" stop="114844082" display_start="114795705" display_stop="114844082" variantLength="48378" />
      </Location>
      <OtherNameList>
        <Name>48-KB DUP, EX2-9DUP</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.114795705_114844082dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.114795705_114844082dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601620.0010" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000012.11:g.114795705_114844082dup AND Holt-Oram syndrome" Accession="RCV000415566" Version="1">
        <ClassifiedConditionList TraitSetID="2174">
          <ClassifiedCondition DB="MedGen" ID="C0265264">Holt-Oram syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-01-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-23" MostRecentSubmission="2017-01-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22333898</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2174" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2051" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TBX5-Related Holt-Oram Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Holt-Oram syndrome</ElementValue>
                <XRef ID="Holt-Oram+syndrome/3457" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007732" DB="MONDO" />
                <XRef ID="19092004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ventriculo-radial syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Atrio digital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiac-limb syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Heart-hand syndrome, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOS 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOS1</ElementValue>
                <XRef Type="MIM" ID="142900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HOS</ElementValue>
                <XRef Type="MIM" ID="142900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Holt-Oram syndrome (HOS) is characterized by upper-limb defects, congenital heart malformation, and cardiac conduction disease. Upper-limb malformations may be unilateral, bilateral/symmetric, or bilateral/asymmetric and can range from triphalangeal or absent thumb(s) to phocomelia. Other upper-limb malformations can include unequal arm length caused by aplasia or hypoplasia of the radius, fusion or anomalous development of the carpal and thenar bones, abnormal forearm pronation and supination, abnormal opposition of the thumb, sloping shoulders, and restriction of shoulder joint movement. An abnormal carpal bone is present in all affected individuals and may be the only evidence of disease. A congenital heart malformation is present in 75% of individuals with HOS and most commonly involves the septum. Atrial septal defect and ventricular septal defect can vary in number, size, and location. Complex congenital heart malformations can also occur in individuals with HOS. Individuals with HOS with or without a congenital heart malformation are at risk for cardiac conduction disease. While individuals may present at birth with sinus bradycardia and first-degree atrioventricular (AV) block, AV block can progress unpredictably to a higher grade including complete heart block with and without atrial fibrillation.</Attribute>
                <XRef ID="NBK1111" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301290</ID>
                <ID Source="BookShelf">NBK1111</ID>
              </Citation>
              <XRef ID="392" DB="Orphanet" />
              <XRef ID="C0265264" DB="MedGen" />
              <XRef ID="MONDO:0007732" DB="MONDO" />
              <XRef Type="MIM" ID="142900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="964388" SubmissionDate="2017-01-11" DateLastUpdated="2017-01-23" DateCreated="2017-01-23">
        <ClinVarSubmissionID localKey="601620.0010_HOLT-ORAM SYNDROME" title="TBX5, 48-KB DUP, EX2-9DUP_HOLT-ORAM SYNDROME" />
        <ClinVarAccession Accession="SCV000493927" DateUpdated="2017-01-23" DateCreated="2017-01-23" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a 5-generation family segregating an atypical form of Holt-Oram syndrome (142900), Patel et al. (2012) identified a 48-kb duplication at chromosome 12q24.21 (chr12.114,795,705-114,844,082, GRCh37) encompassing exons 2 through 9 of the TBX5 gene, with breakpoints within introns 1 and 9. The duplication, which was identified by array CGH and multiplex ligation-dependent probe amplification (MLPA), segregated with the disorder in the family. Patel et al. (2012) proposed that the intragenic duplication could be in-frame and cause its effects through an elongated protein that leads to a gain of function; an elongated protein with abnormal cellular localization mimicking functional haploinsufficiency; or increased expression of the TBX5 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">22333898</ID>
              </Citation>
              <XRef DB="OMIM" ID="142900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX5" />
          </GeneList>
          <Name>TBX5, 48-KB DUP, EX2-9DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">48-KB DUP, EX2-9DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601620.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HOLT-ORAM SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="964388" TraitType="Disease" MappingType="Name" MappingValue="HOLT-ORAM SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265264" Name="Holt-Oram syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

